Evotec SE (EVO) Treasury Shares (2025 - 2026)

Evotec SE's (EVO) quarterly Treasury Shares came in at -$1333.5 in Q1 2026, up 26.0% quarter-over-quarter from -$1801.9 in Q4 2025.

Evotec SE (EVO) Treasury Shares (2025 - 2026) Analysis & Trends

Evotec SE has disclosed Treasury Shares across 2 years of filings, most recently posting -$1333.5 for Q1 2026.

Treasury Shares for Q1 2026 came in at -$1333.5, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$1333.5 (changed N/A YoY), and the FY2025 annual result was -$1801.9, changed N/A from the prior year.
Treasury Shares came in at -$1333.5 for Q1 2026 at Evotec SE, up from -$1801.9 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of -$1333.5 in Q1 2026 to a low of -$1801.9 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	107.00 Mn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	4.80 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	1.42 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	17.13 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	7.24 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	19.58 Mn
10	Evotec SE	583.10 Mn	582.58 Mn	-	-1,333.48

Download Data